From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies
Accurate sample size estimation is essential in prevalence studies to ensure statistically valid conclusions and efficient resource allocation. This technical note presents an approach for estimating sample size in prevalence studies of Anaplasma phagocytophilum in equines. A preliminary PCR-based s...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional del Nordeste
2026
|
| Materias: | |
| Acceso en línea: | https://revistas.unne.edu.ar/index.php/vet/article/view/9106 |
| Aporte de: |
| id |
I48-R154-article-9106 |
|---|---|
| record_format |
ojs |
| spelling |
I48-R154-article-91062026-02-04T15:47:47Z From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies De los datos preliminares al diseño robusto: estimación de muestras para estudios de Anaplasma phagocytophilum y otros estudios de prevalencia Araúz, Anayansi Santana Bolívar, Ángel Morales Allard, Joel Alexis De Sedas Muñoz, Abraham Añino Ramos, Yostin Jesús Agrazal, Karla Jeanneette Romero, Emilio Prevalence studies Precision Sample size ScalaR estudios de prevalencia precisión tamaño de muestra ScalaR Accurate sample size estimation is essential in prevalence studies to ensure statistically valid conclusions and efficient resource allocation. This technical note presents an approach for estimating sample size in prevalence studies of Anaplasma phagocytophilum in equines. A preliminary PCR-based survey in Panama detected one positive case among 36 animals (2.78%). Based on these results, expected prevalences of 2%, 3%, 8%, and 9% were used to model future sample sizes using the ScalaR function in R, incorporating absolute precisions (± 0.75%, ± 1.5%, ± 2%) and a 10% adjustment for potential data loss. The estimated sample sizes ranged from 233 (2% prevalence, ± 1.9%) to 6,216 animals (9% prevalence, ± 0.75%). These findings illustrate how minor variations in assumed prevalence or desired precision can substantially influence the sample size required for reliable epidemiological surveillance. La estimación precisa del tamaño de la muestra es esencial en los estudios de prevalencia para garantizar conclusiones estadísticamente válidas y un uso eficiente de los recursos. Esta nota técnica presenta un enfoque de estimación del tamaño de la muestra para estudios de prevalencia de Anaplasma phagocytophilum en equinos. Un estudio preliminar basado en PCR en Panamá arrojó un caso positivo entre 36 animales (2,78%). Con base en esto, se utilizaron prevalencias esperadas del 2%, 3%, 8% y 9% para modelar futuros tamaños de muestra mediante la función ScalaR en R, incorporando precisiones absolutas (± 0,75%, ± 1,5%, ± 2%) y un ajuste por pérdida de datos del 10%. Los tamaños de muestra estimados oscilaron entre 233 (prevalencia del 2%, ± 1,9%) y 6.216 animales (prevalencia del 9%, ± 0,75%). Estas estimaciones destacan cómo pequeños cambios en los supuestos de precisión y prevalencia pueden afectar considerablemente el tamaño de muestra requerido para estudios de vigilancia fiables. Universidad Nacional del Nordeste 2026-02-04 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.unne.edu.ar/index.php/vet/article/view/9106 10.30972/vet.3719106 Revista Veterinaria; Vol. 37 (2026); 1-4 Revista Veterinaria; Vol. 37 (2026); 1-4 1669-6840 1668-4834 spa https://revistas.unne.edu.ar/index.php/vet/article/view/9106/8822 Derechos de autor 2026 Anayansi Araúz, Ángel Santana Bolívar, Joel Alexis Morales Allard, Abraham De Sedas Muñoz, Yostin Jesús Añino Ramos, Karla Jeanneette Agrazal, Emilio Romero https://creativecommons.org/licenses/by-nc/4.0 |
| institution |
Universidad Nacional del Nordeste |
| institution_str |
I-48 |
| repository_str |
R-154 |
| container_title_str |
Revistas UNNE - Universidad Nacional del Noroeste (UNNE) |
| language |
Español |
| format |
Artículo revista |
| topic |
Prevalence studies Precision Sample size ScalaR estudios de prevalencia precisión tamaño de muestra ScalaR |
| spellingShingle |
Prevalence studies Precision Sample size ScalaR estudios de prevalencia precisión tamaño de muestra ScalaR Araúz, Anayansi Santana Bolívar, Ángel Morales Allard, Joel Alexis De Sedas Muñoz, Abraham Añino Ramos, Yostin Jesús Agrazal, Karla Jeanneette Romero, Emilio From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| topic_facet |
Prevalence studies Precision Sample size ScalaR estudios de prevalencia precisión tamaño de muestra ScalaR |
| author |
Araúz, Anayansi Santana Bolívar, Ángel Morales Allard, Joel Alexis De Sedas Muñoz, Abraham Añino Ramos, Yostin Jesús Agrazal, Karla Jeanneette Romero, Emilio |
| author_facet |
Araúz, Anayansi Santana Bolívar, Ángel Morales Allard, Joel Alexis De Sedas Muñoz, Abraham Añino Ramos, Yostin Jesús Agrazal, Karla Jeanneette Romero, Emilio |
| author_sort |
Araúz, Anayansi |
| title |
From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| title_short |
From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| title_full |
From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| title_fullStr |
From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| title_full_unstemmed |
From preliminary data to robust design: sample estimation for Anaplasma phagocytophilum and other prevalence studies |
| title_sort |
from preliminary data to robust design: sample estimation for anaplasma phagocytophilum and other prevalence studies |
| description |
Accurate sample size estimation is essential in prevalence studies to ensure statistically valid conclusions and efficient resource allocation. This technical note presents an approach for estimating sample size in prevalence studies of Anaplasma phagocytophilum in equines. A preliminary PCR-based survey in Panama detected one positive case among 36 animals (2.78%). Based on these results, expected prevalences of 2%, 3%, 8%, and 9% were used to model future sample sizes using the ScalaR function in R, incorporating absolute precisions (± 0.75%, ± 1.5%, ± 2%) and a 10% adjustment for potential data loss. The estimated sample sizes ranged from 233 (2% prevalence, ± 1.9%) to 6,216 animals (9% prevalence, ± 0.75%). These findings illustrate how minor variations in assumed prevalence or desired precision can substantially influence the sample size required for reliable epidemiological surveillance. |
| publisher |
Universidad Nacional del Nordeste |
| publishDate |
2026 |
| url |
https://revistas.unne.edu.ar/index.php/vet/article/view/9106 |
| work_keys_str_mv |
AT arauzanayansi frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT santanabolivarangel frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT moralesallardjoelalexis frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT desedasmunozabraham frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT aninoramosyostinjesus frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT agrazalkarlajeanneette frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT romeroemilio frompreliminarydatatorobustdesignsampleestimationforanaplasmaphagocytophilumandotherprevalencestudies AT arauzanayansi delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT santanabolivarangel delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT moralesallardjoelalexis delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT desedasmunozabraham delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT aninoramosyostinjesus delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT agrazalkarlajeanneette delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia AT romeroemilio delosdatospreliminaresaldisenorobustoestimaciondemuestrasparaestudiosdeanaplasmaphagocytophilumyotrosestudiosdeprevalencia |
| first_indexed |
2026-02-17T05:00:48Z |
| last_indexed |
2026-02-17T05:00:48Z |
| _version_ |
1857347332906942464 |